Ruby L.Y. Chan

1.2k total citations
12 papers, 685 citations indexed

About

Ruby L.Y. Chan is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Ruby L.Y. Chan has authored 12 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Complementary and alternative medicine and 2 papers in Pharmacology. Recurrent topics in Ruby L.Y. Chan's work include Traditional Chinese Medicine Analysis (4 papers), Bioactive Natural Diterpenoids Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Ruby L.Y. Chan is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Bioactive Natural Diterpenoids Research (2 papers) and RNA Interference and Gene Delivery (2 papers). Ruby L.Y. Chan collaborates with scholars based in Hong Kong, China and United States. Ruby L.Y. Chan's co-authors include Lin Zhang, William Ka Kei Wu, Jing Shen, Tao Hu, Mingxing Li, Lan Lu, Kenneth K.W. To, Lin Wang, Chi H. Cho and Shun X. Ren and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Ruby L.Y. Chan

12 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruby L.Y. Chan Hong Kong	9	445	166	139	101	98	12	685
Se-Jung Lee South Korea	16	327 0.7×	45 0.3×	123 0.9×	94 0.9×	99 1.0×	20	689
Hairong Sang United States	8	395 0.9×	40 0.2×	95 0.7×	185 1.8×	58 0.6×	9	637
Hong Yi China	20	489 1.1×	28 0.2×	119 0.9×	73 0.7×	172 1.8×	63	893
Huaidong Hu China	17	418 0.9×	22 0.1×	183 1.3×	136 1.3×	201 2.1×	29	864
Weilian Bao China	14	294 0.7×	16 0.1×	56 0.4×	82 0.8×	68 0.7×	26	523
Lihua Song China	16	401 0.9×	17 0.1×	102 0.7×	98 1.0×	171 1.7×	27	650
Qiongming Xu China	9	254 0.6×	16 0.1×	44 0.3×	97 1.0×	61 0.6×	10	424
Chi Hin Cho Hong Kong	13	377 0.8×	10 0.1×	175 1.3×	119 1.2×	84 0.9×	17	765
Chunhua Ma China	14	413 0.9×	11 0.1×	43 0.3×	108 1.1×	75 0.8×	33	705
Kuei-Li Lin Taiwan	12	284 0.6×	13 0.1×	119 0.9×	31 0.3×	60 0.6×	13	503

Countries citing papers authored by Ruby L.Y. Chan

Since Specialization

Citations

This map shows the geographic impact of Ruby L.Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby L.Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby L.Y. Chan more than expected).

Fields of papers citing papers by Ruby L.Y. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby L.Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby L.Y. Chan. The network helps show where Ruby L.Y. Chan may publish in the future.

Co-authorship network of co-authors of Ruby L.Y. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby L.Y. Chan. A scholar is included among the top collaborators of Ruby L.Y. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby L.Y. Chan. Ruby L.Y. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

DiCara, Danielle, Ruby L.Y. Chan, James A. Ernst, et al.. (2018). High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants. mAbs. 10(7). 1–11. 17 indexed citations

2.

Wang, Lin, Tao Hu, Jing Shen, et al.. (2016). Miltirone induced mitochondrial dysfunction and ROS-dependent apoptosis in colon cancer cells. Life Sciences. 151. 224–234. 39 indexed citations

3.

Dunshee, Diana, Travis W. Bainbridge, Noelyn M. Kljavin, et al.. (2016). Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21. Journal of Biological Chemistry. 291(11). 5986–5996. 117 indexed citations

4.

Hu, Tao, Lin Wang, Lin Zhang, et al.. (2015). Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity. Phytomedicine. 22(5). 536–544. 78 indexed citations

5.

Wang, Lin, Tao Hu, Jing Shen, et al.. (2015). Dihydrotanshinone I induced apoptosis and autophagy through caspase dependent pathway in colon cancer. Phytomedicine. 22(12). 1079–1087. 62 indexed citations

6.

Hu, Tao, Kenneth K.W. To, Lin Wang, et al.. (2014). Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 21(11). 1264–1272. 84 indexed citations

7.

Ren, Shun X., Jin Song Shen, Alfred S.L. Cheng, et al.. (2013). FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells. PLoS ONE. 8(5). e63641–e63641. 127 indexed citations

8.

Yeung, J.H.K., Tao Hu, Wayne Lee, et al.. (2013). Dihydrotanshinone induces p53-independent but ROS-dependent apoptosis in colon cancer cells. Life Sciences. 93(8). 344–351. 38 indexed citations

9.

Ren, Shun X., Alfred S.L. Cheng, Ka‐Fai To, et al.. (2012). Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer. Cancer Research. 72(24). 6512–6523. 115 indexed citations

10.

Shen, Jing, William Ka Kei Wu, Shun X. Ren, et al.. (2012). miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications. Current Pharmaceutical Design. 19(7). 1301–1310. 5 indexed citations

11.

Shen, Jing, William Ka Kei Wu, Shun X. Ren, et al.. (2012). miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications. Current Pharmaceutical Design. 19(7). 1301–1310. 1 indexed citations

12.

Chan, Ruby L.Y., et al.. (2001). Asia's Performance Challenge. The McKinsey Quarterly. 6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact